These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 14631679)

  • 1. [Treatment of spasticity with botulinum toxin].
    Eleopra R; Quatrale R; Tugnoli V
    J Neurosurg Sci; 2003 Mar; 47(1 Suppl 1):68-73. PubMed ID: 14631679
    [No Abstract]   [Full Text] [Related]  

  • 2. [Botulinum toxin in the treatment of spasticity].
    Arriola-Arellano E; Chacón J; Alvarez-López M; Balbuena-García M; Fuentes-Pradera J; Vicente-Baz D
    Rev Neurol; 2006 Feb 16-28; 42(4):250-1. PubMed ID: 16521066
    [No Abstract]   [Full Text] [Related]  

  • 3. Botulinum toxin should be first-line treatment for poststroke spasticity.
    Sheean G
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):359. PubMed ID: 19289475
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gait.
    O'Brien CF
    Adv Neurol; 2001; 87():265-9. PubMed ID: 11347231
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of spasticity in adults: practical application of botulinum toxin.
    Pathak MS; Nguyen HT; Graham HK; Moore AP
    Eur J Neurol; 2006 Feb; 13 Suppl 1():42-50. PubMed ID: 16417597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spasticity and botulinum toxin in 2003. An update].
    Fève A
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):265-70. PubMed ID: 12746701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin for treatment of spasticity in adults.
    Reichel G
    J Neurol; 2001 Apr; 248 Suppl 1():25-7. PubMed ID: 11357235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
    Fève A; Decq P; Filipetti P; Kéravel Y
    Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal cord injury and use of botulinum toxin in reducing spasticity.
    Fried GW; Fried KM
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):901-10. PubMed ID: 14580044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum toxin in the treatment of cerebral palsy: case conference].
    Nezu A; Takahashi Y
    No To Hattatsu; 2011 Mar; 43(2):136-8. PubMed ID: 21409836
    [No Abstract]   [Full Text] [Related]  

  • 11. The current use of botulinum toxin.
    Mahant N; Clouston PD; Lorentz IT
    J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin--mechanisms of action and clinical use in spasticity.
    Barnes M
    J Rehabil Med; 2003 May; (41 Suppl):56-9. PubMed ID: 12817658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment with botulinum toxin in neurologic pediatrics].
    Justus N; Lee SH; Berweck S; Heinen F
    Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
    [No Abstract]   [Full Text] [Related]  

  • 14. Botulinum toxin in the management of spasticity in adults.
    Turner-Stokes L; Ward A
    Clin Med (Lond); 2002; 2(2):128-30. PubMed ID: 11991094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Botulinum toxins for pain].
    Soinila S; Haanpää M
    Duodecim; 2011; 127(22):2425-30. PubMed ID: 22238920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of spasticity.
    Hesse S; Mauritz KH
    Curr Opin Neurol; 1997 Dec; 10(6):498-501. PubMed ID: 9425564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safe administration of muscle-relaxing botulismotoxin during treatment for leukemia.
    Lo Nigro L; Costantino F; Schilirò G
    Med Pediatr Oncol; 2002 Feb; 38(2):150. PubMed ID: 11813194
    [No Abstract]   [Full Text] [Related]  

  • 18. [Botulinum toxin and the hospital pharmacy].
    Villart M
    Ann Pharm Fr; 2007 Sep; 65(5):342-6. PubMed ID: 17982382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of botulinum toxin for the treatment of muscle spasticity in the first 2 years of life.
    Bakheit AM
    Int J Rehabil Res; 2010 Jun; 33(2):104-8. PubMed ID: 19574925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.
    Teasell R; Foley N; Pereira S; Sequeira K; Miller T
    Top Stroke Rehabil; 2012; 19(2):115-21. PubMed ID: 22436359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.